Carson Wealth (CWM LLC)’s NeuroSense Therapeutics NRSN Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NRSN Stock Details NRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,000	Closed	-$1K	–	5545
2025 Q3	$1K	Hold	1,000	–	–	﹤0.01%	5163
2025 Q2	$2K	Hold	1,000	–	–	﹤0.01%	4906
2025 Q1	$1K	Hold	1,000	–	–	﹤0.01%	4955
2024 Q4	$1K	Hold	1,000	–	–	﹤0.01%	4757
2024 Q3	$1K	Hold	1,000	–	–	﹤0.01%	4650
2024 Q2	$1K	Hold	1,000	–	–	﹤0.01%	4436
2024 Q1	$2K	Hold	1,000	–	–	﹤0.01%	4012
2023 Q4	$1K	Hold	1,000	–	–	﹤0.01%	3994
2023 Q3	$1K	Hold	1,000	–	–	﹤0.01%	4030
2023 Q2	$1K	Hold	1,000	–	–	﹤0.01%	4019
2023 Q1	$2K	Hold	1,000	–	–	﹤0.01%	3680
2022 Q4	$1K	Hold	1,000	–	–	﹤0.01%	3797
2022 Q3	$2K	Buy	+1,000	New	+$2.05K	﹤0.01%	3505

Other funds holding NRSN

YAG

Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Carson Wealth (CWM LLC)'s NRSN Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of NeuroSense Therapeutics (NRSN) in Q4 2025, closing a stake of 1,000 shares — an estimated $1K sold.

Carson Wealth (CWM LLC) first reported a position in NRSN in Q3 2022 and held it in 13 quarters. The position peaked at $2K in Q2 2025. 13 funds tracked by Wall St. Rank hold NRSN as of Q4 2025.

Carson Wealth (CWM LLC) reported no remaining NeuroSense Therapeutics position as of Q4 2025 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 1,000 NeuroSense Therapeutics shares in Q4 2025, an estimated $1K.
Carson Wealth (CWM LLC) first reported a position in NeuroSense Therapeutics in Q3 2022 and held it in 13 quarters.
Carson Wealth (CWM LLC)'s NeuroSense Therapeutics position peaked at $2K in Q2 2025.
13 funds tracked by Wall St. Rank held NeuroSense Therapeutics as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.